Smoking cessation and cardiovascular disease risk factors: Results from the Third National Health and Nutrition Examination Survey

被引:165
作者
Bakhru, A [1 ]
Erlinger, TP
机构
[1] Univ Rochester, Med Ctr, Sch Med, Rochester, NY 14642 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
[3] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[5] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA
关键词
D O I
10.1371/journal.pmed.0020160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cigarette smoking is a major risk factor for the development and progression of cardiovascular disease. While smoking is associated with increased levels of inflammatory markers and accelerated atherosclerosis, few studies have examined the impact of smoking cessation on levels of inflammatory markers. The degree and rate at which inflammation subsides after smoking cessation are uncertain. It also remains unclear as to whether traditional risk factors can adequately explain the observed decline in cardiovascular risk following smoking cessation. Methods and Findings Using data from 15,489 individuals who participated in the Third National Health and Nutrition Examination Survey (NHANES III), we analyzed the association between smoking and smoking cessation on levels of inflammatory markers and traditional cardiovascular risk factors. In particular, we examined changes in C-reactive protein, white blood cell count, albumin, and fibrinogen. Inflammatory markers demonstrated a dose-dependent and temporal relationship to smoking and smoking cessation. Both inflammatory and traditional risk factors improved with decreased intensity of smoking. With increased time since smoking cessation, inflammatory markers resolved more slowly than traditional cardiovascular risk factors. Conclusion Inflammatory markers may be more accurate indicators of atherosclerotic disease. Inflammatory markers returned to baseline levels 5 y after smoking cessation, consistent with the time frame associated with cardiovascular risk reduction observed in both the MONICA and Northwick Park Heart studies. Our results suggest that the inflammatory component of cardiovascular disease resulting from smoking is reversible with reduced tobacco exposure and smoking cessation.
引用
收藏
页码:528 / 536
页数:9
相关论文
共 61 条
  • [1] ABERG A, 1983, BRIT HEART J, V49, P416, DOI 10.1136/hrt.49.5.416
  • [2] Ablij H C, 2003, Ned Tijdschr Geneeskd, V147, P15
  • [3] Overexpressed nuclear factor-κB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPβ and signal transducer and activator of transcription-3
    Agrawal, A
    Cha-Molstad, H
    Samols, D
    Kushner, I
    [J]. IMMUNOLOGY, 2003, 108 (04) : 539 - 547
  • [4] [Anonymous], 1996, AN REP GUID 3 NAT HL
  • [5] Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States
    Bazzano, LA
    He, J
    Muntner, P
    Vupputuri, S
    Whelton, PK
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (11) : 891 - 897
  • [6] Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment
    Benowitz, NL
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2003, 46 (01) : 91 - 111
  • [7] C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events
    Blake, GJ
    Ridker, PM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) : 1512 - 1513
  • [8] C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells
    Blaschke, F
    Bruemmer, D
    Yin, F
    Takata, Y
    Wang, W
    Fishbein, MC
    Okura, T
    Higaki, J
    Graf, K
    Fleck, E
    Hsueh, WA
    Law, RE
    [J]. CIRCULATION, 2004, 110 (05) : 579 - 587
  • [9] Bottcher M, 1999, J CARDIOVASC RISK, V6, P299
  • [10] The Rel family member p50 mediates cytokine-induced C-reactive protein expression by a novel mechanism
    Cha-Molstad, H
    Agrawal, A
    Zhang, DX
    Samols, D
    Kushner, I
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (08) : 4592 - 4597